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S _ry The expreson of sialyl Tn (STn) antigen in 180 patients with Borrmann type IV gastric
inos was eamined immunohtochemialy. The ratc of positrve STn staining was 32% (57/180) for the
prmary tumours, and this positive staining corrdated well with tumour extension, lymph node metastasis
(P<0.05) and peritoneal disseminatio (P<0.01). One-third (5/15) of patients with positie STn-staining
cancer cefls had a high klv of serm STn. Lesons with postive Sin staining we related to a lower survwial
rate for the patients (P<0.05). Proiferativ actiity of the tumour, as measured by proliferating nudcear
antigen (PCNA) pecentage and argrophilic nuckelar organisr region (AgNOR) count, was
significantly higher (41.5 ± 13.0%, 3.78 ± 0.98) in the STn-postive group than in the STn-negative group
(34.2± 1312%, 3.48 ± 0.85) (P<0.01, P<0.05 respectively). Estimating STn antigen may be useful for
prediting the likelihood of lymph node metastass or peritoneal dissemination and the clinical prognosis for
patients with Borrmann type IV gastric carcnoma
lK w.rc sialyl Tn antigen; Borrmann type IV; gastric lymphatic astasis
Despite advances in diagnostic and surgical management,
patients with Borrmann type IV gastric carcinoma have a
poor prognosis. Advanced carcinoma of the stomach can be
clasified, based on Borrmann's criteria, into one of four
types (Borrmann, 1926). Borrmann type I carcinoma is a
polypoid fungating, type H uklcrative lesion with elevated
and distinct borders, and type HI is ulcerative but with
initinct borders. Borrmann type IV carcnoma is a diffuse
malignant lesion with indit borders, and is usually
identified only at a very advanced stage (Borchard, 1990;
Maehara et al., 1992). The lack of sharp borders of the
tumour can make for an underestimation of size. The clinical
course is usually unfavourable and the 5 year survival rates
are 0-20% (Furukawa et al., 1988; Maehara et al., 1992). A
detailed study focusing on the biological behaviour of these
highly malignant carcinomas may perhaps improve the prog-
nosis.
Associated with neoplastic transformation, incomplete syn-
thesis of glycolipids or glycoproteins in celi membranes often
occurs, resulting in a storage of precursor suctures that, in
normal cells, would remain cryptic because of further elonga-
tion (Hakomori and Kannagi, 1983; Springer, 1984). Sialyl
Tn antigen (STn) is one of these abnormal 0-linked glyco-
proteins. The Tn antigen is a precursor of the Thomsen-
Freidenreich antigen, the T antigen, and STn is a sialic
acid-bound Tn antigen (Hakomori and Kannagi, 1983;
Springer, 1984; Kjeldsen et al., 1988). The relationship
between STn expresson and biological-behaviour of cacer
cls has been investigated in some human malignncies. In
colonic tissues, Itzkowitz et al. (1990) reported a poor out-
come for STn antigen-positive patients. Kobayashi et al.
(1992) concluded that a positive STn antigen in sera was an
independent predictor of a poor prognoss in patients with
ovarian cancer. We reported that elevated serum STn klvels
correlate with advanced tumour stage and a worse prognosis
ofpatients with gastric cancer (Takahashi et al., 1993, 1994).
Immunobistochemically, Ma et al. (1993) and Werther et al.
(1994) reported that expression of STn antigen may be a
useful prognostic marker in patients with gastric cancer.
However, the question remained as to whether the lower
survival rate of patients with higher STn expression relects a
higher tumour burden.
To better undestand the biological behaviour of STn-
positive cancer cells in the most advanced stage, we per-
formed inmunostaining for STn antigen in Borrmann type
IV gastric cancer and the relationship between STn expres-
sion and clinicopathological features was examined with
regard to clinical prognosis. We also analysed cell proli-
ferative activity determined by proliferating nuclear antigen
(PCNA) labelling percentage and argyrophilic nucleolar
organiser region (AgNOR) count, both serving as a para-
meter of proliferating cells (Egan & Crocker, 1993; McCor-
mick & HalL 1992).
MMaerial and
Patients
The 180 Japanese patients with primary Borrmann type IV
gastric cancer studied herein had undergone gastrectomy m
the National Kyushu Cancer Center, Fukluolka, Japan, from
1972 to 1990. A thorough histological examination was made
on haematoxylin and eosinained preparations, and the
histological classification was according to the tumour-
node-metastasis classifation system of the International
Union Against Cancer (UICC, 1987). No patient had been
given cytotoxic drugs preoperatively. Post-operative adjuvant
chemotherapy was prescribed for 171 patients.
Immunohistochemical stainingfor STn
Sections from paraffin blocks were dewaxed and stained
using the avidin-biotin-peroxidase complex method. The
primary antibody TKH2, a monoclonal mouse antibody for
sialosyl Tn antigen, was kindly provided by Otsuka Assay
Laboratory (Tokushima, Japan). The slides were incubated
with fresh 0.3% hydrogen peroxide in methanol for 10 min,
then washed three times with phosphate-buffered saline (PBS;
pH 7.4). Five per cent normal goat serun in PBS was then
applied for 15 min. The sections were incubated overnight
with TKH2 (dilution 1:50) at room temperature, with bio-
tinylated goat anti-mouse IgG (1:200 for 30 min Vector
Laboratories) and with the avidin-biotin-peroxidase com-
plex (for 30min; Vector Laboratories). Peroxidase la g
was developed with 3,3'-diaminobenzidine and hydrogen per-
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oxide and the sections were counterstained with haematoxy-
lin.
To ensure the consistency of STn staining between batches,
a known positive control gastnrc carcinoma was included in
each round. Negative controls were prepared by substituting
normal mouse serum for primary antibody, the results being
no detectable staining.
Cellular localisation of the antigenic sites was determined
by two investigators without knowledge of clinicopatho-
logical information. A double-headed light microscope was
used. Scoring was made by examining all low-power optical
fields (10 x objective) containing tumour cells and the
percentage of antigen-positive cells was estimated. A positive
value was recorded if more than 5% of the tumour cells
expressed STn antigen.
Serum STn levels
Serum STn levels were measured for 27 patients surgically
treated in the period from 1981 to 1986, using a one-step
radioimmunoassay kit (S-Tn Otsuka; Otsuka Assay
Laboratories, Tokushima, Japan) (Imamura et al., 1989).
Competitive binding to the radiolabelled monoclonal
antibody TKH2 between serum STn and STn-coated beads
was used (an immunoradiometnrc competitive inhibition
assay) (Kjeldsen et al., 1988). Venous blood samples were
obtained from patients after an overnight fast and were
immediately centrifuged and the serum placed in liquid nit-
rogen until assay. The cut-off between normal and elevated
STn titres was set at 45 U ml-'; this is the mean +two
standard deviations (s.d.) of the STn value in normal
volunteers, as reported by Imamura et al. (1989).
Proliferative activities
The avidin-biotin-peroxidase complex method was used for
PCNA staining, as described elsewhere (Kakeji et al., 1994).
The primary antibody was PCIO (Dako, Carpinteria, CA,
USA). The PCNA labelling percentage was determined by
observing 1000 nuclei in areas of the section with the highest
labelling percentage, and the percentage of PCNA-labelled
nuclei was used for analysis. For AgNOR staining, the one-
step silver colloid method was used. The NOR staining solu-
tion was prepared according to the description of Ploton et
al. (1982). On the AgNOR-stained slides, careful focusing
made visible the AgNOR in the nucleus, in the form of black
dots. One hundred cells from each lesion were analysed and a
mean score of AgNOR count was recorded.
Statistical analysis
Clinicopathological data were stored in an IBM (Armonk,
NY, USA) 4381 mainframe computer. The Biomedical Com-
puter Program (BMDP) was used for all statistical analyses
(Dixon, 1988). The BMDP P4F and P3S programs were used
for the chi-square test, and the Mann-Whitney test was used
to compare characteristics between positive and negative
groups with STn staining. The BMDP PIL program was
used for analysing survival rates, together with the Kaplan-
Meier method, and for testing equality of survival curves,
using the method of Mantel and Cox. In the statistical
analysis, deaths due to causes other than gastric carcinoma
were considered censored cases.
Results
STn staining and clinicopathological characteristics
In the normal gastric mucosa, positive staining for STn was
recognised in parietal cells with STn expression in intracel-
lular canalicular membranes. In cancer tissues, the intensity
and incidence of staining varied widely from case to case and
from area to area within one case. In general, however, the
staining was diffusely cytoplasmic, with strong staining assoc-
iated with the luminal surface (Figure 1). Positive STn stain-
ing was evident in 57 (32%) of 180 pnrmary tumours. No
obvious relation was found between STn staining and the
gender or age of the patient (Table I). All seven patients in
whom tumour invasion was confined to the subserosa (T2)
showed negative STn staining, and the rate of positive stain-
ing increased in proportion to invasion into the deeper layers
(P<0.05). STn-positive tumours were associated with a
higher incidence of metastasis to lymph nodes and peritoneal
dissemination than were STn-negative tumours (P<0.05,
P<0.01, respectively).
STn staining and serum STn level
Table II shows the compatibility of histopathological STn
staining and serum STn level. Although the patient numbers
were too few for a statistical significance, the data do provide
interesting information. All 12 with STn-negative cancer cells
in tissues had a low level of serum STn, and one-third (5/15)
of the patients with STn-positive cancer cells had a high level
of serum STn. Table III shows clinicopathological features of
patients with immunohistochemically STn-positive cancer
cells, according to serum STn levels. In this analysis of 15
cases, there were no obvious features in patients with high
STn levels in tissues or in serum. Though not statistically
significant, the mean survival time for patients with high
serum STn levels (>45Urml-1) was 298 (131-474) days,
that is much shorter than the 778 (148-2932) days for those
with low serum STn levels (<45 U ml-').
STn staining and prognosis
The overall survival curve is shown in Figure 2a, according
to positive or negative STn staining. Those with positive STn
cancers showed worse survival rates than did those with
negative STn cancers (P<0.05). Even in 'curative' cases,
there was a tendency toward a shorter survival for those with
positive STn cancers (Figure 2b). Table IV shows the pattern
of recurrence, based on STn staining. Though the recurrence
rate tended to be higher in patients with STn-positive
tumours (13/18; 72%) than that in those with STn-negative
tumours (38/65; 58%), no obvious difference was recognised
in the pattern of recurrences.
STn staining andproliferative activity
The proliferative activity expressed by mean PCNA labelling
percentage was 41.5% for STn-positive cases, a value
significantly higher than 34.2% for the STn-negative cases
(P<0.01, Table V). The mean AgNOR count for STn-
positive cases (3.77) was also significantly higher than that
for STn-negative cases (3.48, P<0.05).
Fgwe 1 Gastric carcinoma of moderately differentiated type
stained with TKH-2 antibody and showing both cytoplasmic and
apical reactivity (x 200).Table I Clinicopathological characteristics and STn staining
STn staining
Negative Positive P-
Histologicalfindings (n = 123) (n = 57) value
Sex
Men
Women
Mean age (years)
Tumour size (cm)
Histological type
Well differentiated
Moderately differentiated
Poorly differentiated
Signet
Mucinous
Tumour extension
pT2
pT3
pT4
Invasion into lymphatics
No invasion
Slight invasion
Moderate invasion
Severe invasion
Venous invasion
No invasion
Slight invasion
Moderate invasion
Severe invasion
Lymph node involvement
pNO
pNl
pN2
pMl
Peritoneal dissemination
Negative
Positive
Metastasis to the liver
Negative
Positive
Stage
IA
IB
II
IIIA
IIIB
IV
Curability
Curative
Non-curative
70
53
55.8± 11.7
12.2±4.0
11
51
59
1
7
84
32
8
49
40
26
43
73
6
1
17
28
59
19
28
29
58.6± 14.0
13.2±4.0
2
9
13
26
7
0
31
26
21
14
21
15
36
5
4
8
26
19
98 31
25 26
119 56
4 1
0
1
13
20
32
57
0
0
0
4
10
43
66 17
57 40
NS
NS
NS
NS
P<0.05
NS
NS
P<0.05
P<0.01
NS
P<0.01
P<0.01
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Table m Clinicopathological characteristics of patients with
immunohistochemically STn-positive cancer cells according to serum
STn level
Serun STn level (Uml-')
<45 >45
Histologicalfindings (n=10) (n=5)
Sex
Men
Women
Mean age (years)
Tumour size (cm)
Histological type
Well differentiated
Moderately differentiated
Poorly differentiated
Signet
Mucinous
Tumour extension
pT2
pT3
pT4
Invasion into lymphatics
No invasion
Slight invasion
Moderate invasion
Severe invasion
Venous invasion
No invasion
Slight invasion
Moderate invasion
Severe invasion
Lymph node involvement
pNO
pNl
pN2
pMl
Peritoneal dissemination
Negative
Positive
Metastasis to the liver
Negative
Positive
Stage
IIIB
IV
Curability
Curative
Non-curative
Mean survival (days)
5
5
50.1 ±11.1
12.9± 3.8
3
2
4
0
0
5
5
0
4
3
3
3
7
0
0
4
4
5
5
9
1
9
3
7
778
(148-2932)
4
1
72.8± 7.6*
14.3±2.4
0
1
0
2
2
0
3
2
0
1
1
3
4
0
0
0
0
2
3
4
4
4
2
3
298
(131-474)
*P<0.01.
Table II Compatibility ofhistopathological STn staining and serum
STn level
STn staining
Serun STn level (U ml-') Negative Positive
<45 12 10
>45 0 5
Quantitative differences in cell-surface sialic acid (total cell-
surface sialic acid levels) and qualitative changes in sialylated
oligosaccharides (presence or absence of a particular oligo-
saccharide structure or individual glycoconjugates) are com-
monly associated with metastasis (Yogeeswaran and Salk,
1981; Altevogt et al., 1983; Passaniti and Hart, 1988). The
finding that STn-positive cancers in primary lesions cor-
related with lymph node metastasis and with peritoneal
metastasis suggests that the STn antigen may be drained
specfically by the lymphatic route. The specific drainage
route for tumour cells with special antigen was discussed by
Tabuchi et al. (1990); they stated that CA 19-9, a cancer-
associated antigen with sialylated carbohydrates, may be
drained pfimarily by the thoracic duct of the lymphatic
system via node metastases or invasive lymphatics. Further-
more, tumours with positive STn staining had a higher pro-
liferative activity than did those with which stained nega-
tively. We have previously reported that tumours with a high
proliferative activity often metastasise to lymph nodes
(Kakeji et al., 1991, 1994). Therefore, this high proliferative
activity will probably accelerate the lymphatic spread of
cancer ceLs through association with altered cell membrane
glycoproteis. As patients with Borrmann type IV carcinoma
are more likely to have lymph node metastases and peri-
toneal dissemination than those with other types (Maehara et
al., 1992), STn may be an additional predictor of survival
time for those patients.
Carbohydrate antigens with changes in glycosylation,
detected in patients' serum, have been used as tumourSTn in Br. t_pe IVpsgme cahmr
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100
P= 0.0110
> 50
X) ESTn (-)
STn (+)
0
0 1 2 3 4 5
Years after operation
100
P= 0.05U
> 50 STn (
STn (+)
0
0 1 2 3 4 5
Years after operation
Fire 2 The survival curves of patients with Borrmann type 4
gastric carcinoma. The thin black line indicates cases with STn-
negative tumour and the bold black line indicates those with
STn-positive tumour. a, Survival curves for all patients. There
was a significant difference (P<0.05). b, Survival curves of
'curative' cases.
markers. As for STn antigen, it is not well known whether
the levels of circulating serum STn antigen reflect changes in
expression of this antigen on cancer cell membranes. The
positive rates of STn antigen in immunohistochemical and
serological study have been noted for some human cancers.
In patients with colorectal cancer, the positive rate in tissue
was 88% (112/128) (Itzkowitz et al., 1990) and that in serum
was 28% (5/18) (Motoo et al., 1991). Those rates in patients
with endometrial cancers were 84% (36/43) in tissue (Inoue
et al., 1991) and 5% (2/42) in serum (Inoue et al., 1990). We
found little documentation of comparisons of the STn levels
Table IV STn staining and pattern of recurrence
STn staining
Negative Positive
Pattern ofrecurrence (n = 65) (n = 18}
Peritoneal dissemination 23 5
Metastasis to lymph nodes 4 5
Liver metastasis 4 0
Pulmonary metastasis 2 0
Bony metastasis 0 1
Local recurrence 2 2
Other recurrences 3 0
Total recurrences 38 13
No recurrence 27 5
Table V STn staining and proliferative activity
STn staining (mean±s.d.j
Negative Positive
Proliferative activity (n = 123) (n = 57)
PCNA labelling (%) 34.2±13.2 41.5 13.0**
AgNOR count 3.48±0.85 3.78 0.98*
*P<0.05, **P<0.01.
in tissues and those in sera from the same patients. As for
data on gastric cancer, together with data from our previous
report (Takahashi et al., 1993), we noted a relationship
between the expression of STn by immunohistochemical
staining and the serum STn antigen level. In about one-third
of the cases of gastric cancer, cell-surface STn glycoconjugate
seems to be drained into the systemic circulation. No partic-
ular charactenrstic emerged from cases of ready shedding of
STn antigen into vessels. Patients with elevated serum STn
antigen levels survived for only a short time, perhaps because
of the higher tumour burden.
Even among patients with the same Borrmann type IV
carcinoma, there are variations in lifespan. STn is associated
with lymph node metastasis and peritoneal dissemination in
this lesion, therefore this antigen may be one predictor of
survival time for patients with Borrmann type IV car-
cinoma.
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